MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
MOH on NYSE
Shares outstanding
53,991,938
Price per share
$173.54
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
56,232,696
Total reported value
$10,758,761,896
% of total 13F portfolios
0.01%
Share change
+3,022,622
Value change
+$329,733,330
Number of holders
612
Price from insider filings
$173.54
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRICE T ROWE ASSOCIATES INC /MD/ 6.5% +60% $671,573,327 +$249,218,079 3,509,476 +59% T. Rowe Price Associates, Inc. 30 Sep 2025
AQR CAPITAL MANAGEMENT LLC 5.4% $561,475,117 2,934,130 AQR Capital Management, LLC 30 Sep 2025
Capital Research Global Investors 4% $645,279,105 2,166,093 Capital Research Global Investors 30 Jun 2025
As of 30 Sep 2025, MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) has 612 institutional shareholders filing 13F forms. They hold 56,232,696 shares. .

Top 25 institutional shareholders own 81% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 6,436,745 +0.05% 0.02% $1,231,735,522
Capital World Investors 9.6% 5,167,169 -2% 0.14% $988,790,426
BlackRock, Inc. 8.4% 4,552,764 -3.9% 0.02% $871,216,896
PRICE T ROWE ASSOCIATES INC /MD/ 6.5% 3,503,675 +59% 0.07% $670,464,000
AQR CAPITAL MANAGEMENT LLC 5.4% 2,934,130 +217% 0.36% $561,475,083
HARRIS ASSOCIATES L P 5% 2,682,141 +74% 0.82% $513,254,502
STATE STREET CORP 4.5% 2,413,252 -1.9% 0.02% $461,799,903
FMR LLC 4% 2,154,086 -14% 0.02% $412,205,832
T. Rowe Price Investment Management, Inc. 3.6% 1,969,661 +31% 0.23% $376,915,000
GEODE CAPITAL MANAGEMENT, LLC 2.9% 1,556,761 +2.9% 0.02% $296,809,625
Invesco Ltd. 2.5% 1,361,302 -15% 0.04% $260,498,752
WELLINGTON MANAGEMENT GROUP LLP 2% 1,064,488 -49% 0.04% $203,700,423
MORGAN STANLEY 1.8% 984,624 +64% 0.01% $188,418,031
VICTORY CAPITAL MANAGEMENT INC 1.8% 963,526 +344% 0.12% $184,380,336
DIMENSIONAL FUND ADVISORS LP 1.7% 938,677 +31% 0.04% $179,632,362
Capital Research Global Investors 1.5% 792,786 -63% 0.03% $151,707,529
GOLDMAN SACHS GROUP INC 1.1% 611,169 +94% 0.02% $116,953,390
UBS Group AG 1.1% 603,934 +321% 0.02% $115,568,810
NORTHERN TRUST CORP 1.1% 569,023 +4.9% 0.01% $108,888,242
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.99% 535,450 +28% 0.02% $102,463,712
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.82% 443,254 -21% 0.02% $84,821,085
JACOBS LEVY EQUITY MANAGEMENT, INC 0.69% 369,980 -14% 0.28% $70,799,373
Legal & General Group Plc 0.65% 350,231 +10% 0.02% $67,020,200
RENAISSANCE TECHNOLOGIES LLC 0.59% 320,237 -29% 0.08% $61,280,552
DEUTSCHE BANK AG\ 0.59% 317,995 +4.8% 0.02% $60,851,524

Institutional Holders of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 390,911 $67,885,815 +$35,850,559 $173.54 19
2025 Q3 56,232,696 $10,758,761,896 +$329,733,330 $191.36 612
2025 Q2 53,143,939 $15,814,934,813 -$59,517,797 $297.90 618
2025 Q1 53,318,205 $17,556,102,058 +$91,035,750 $329.39 612
2024 Q4 53,180,378 $15,477,621,179 -$852,971,475 $291.05 628
2024 Q3 55,753,451 $19,199,929,619 -$928,756,074 $344.56 610
2024 Q2 58,617,870 $17,425,900,732 +$502,372,416 $297.30 627
2024 Q1 56,839,623 $23,335,901,599 -$303,649,044 $410.83 621
2023 Q4 57,640,016 $20,824,881,449 -$191,782,820 $361.31 606
2023 Q3 58,035,242 $19,033,464,556 +$26,719,197 $327.89 561
2023 Q2 58,046,345 $17,471,402,448 +$426,522,422 $301.24 548
2023 Q1 56,729,472 $15,178,264,132 +$33,384,895 $267.49 546
2022 Q4 56,448,873 $18,625,852,402 +$134,989,897 $330.22 581
2022 Q3 55,952,221 $18,459,660,351 -$700,204,160 $329.84 551
2022 Q2 55,992,273 $15,655,695,586 -$92,545,148 $279.61 526
2022 Q1 56,374,176 $18,803,260,968 +$567,775,786 $333.59 520
2021 Q4 54,698,996 $17,382,776,386 -$297,657,640 $318.08 492
2021 Q3 55,513,549 $15,064,016,057 +$42,459,082 $271.31 430
2021 Q2 55,433,976 $14,030,996,303 -$50,623,023 $253.06 439
2021 Q1 55,652,660 $13,003,593,070 +$32,452,819 $233.76 422
2020 Q4 55,362,449 $11,770,646,504 -$359,881,893 $212.68 401
2020 Q3 57,178,239 $10,437,229,069 -$222,139,739 $183.04 398
2020 Q2 58,643,576 $10,433,524,476 -$428,183,799 $177.98 382
2020 Q1 61,041,787 $8,525,814,696 -$434,479,963 $139.71 302
2019 Q4 64,018,482 $8,685,900,134 +$494,991,927 $135.69 312
2019 Q3 60,660,923 $6,653,658,605 -$49,419,011 $109.72 317
2019 Q2 60,840,490 $8,703,029,811 -$217,561,694 $143.14 348
2019 Q1 62,947,103 $8,934,940,390 -$384,967,248 $141.96 344
2018 Q4 65,790,046 $7,645,679,751 -$202,642,162 $116.22 325
2018 Q3 67,173,819 $9,986,021,845 -$614,369,095 $148.70 331
2018 Q2 71,841,887 $7,037,065,091 +$143,805,477 $97.94 279
2018 Q1 70,629,576 $5,733,843,081 +$630,570,785 $81.18 243
2017 Q4 63,342,111 $4,857,698,998 +$245,115,033 $76.68 255
2017 Q3 60,388,393 $4,135,781,700 +$335,652,139 $68.76 224
2017 Q2 55,496,751 $3,839,489,833 +$191,487,117 $69.18 252
2017 Q1 53,439,588 $2,437,065,991 +$230,867,478 $45.60 236
2016 Q4 52,138,210 $2,828,569,010 +$41,116,959 $54.26 267
2016 Q3 51,271,872 $2,988,235,451 +$89,952,890 $58.32 271
2016 Q2 50,125,722 $2,501,756,289 -$2,495,209 $49.90 258
2016 Q1 49,184,618 $3,171,610,444 -$93,996,347 $64.49 273
2015 Q4 51,183,454 $3,078,020,154 +$98,104,406 $60.13 279
2015 Q3 49,088,384 $3,379,009,154 +$123,091,858 $68.85 293
2015 Q2 47,493,817 $3,338,369,536 +$455,102,078 $70.30 266
2015 Q1 40,922,320 $2,753,370,094 +$160,526,226 $67.29 229
2014 Q4 38,827,360 $2,078,331,791 +$80,090,293 $53.53 194
2014 Q3 37,996,322 $1,607,229,286 +$28,971,330 $42.30 188
2014 Q2 37,122,189 $1,656,318,055 +$102,329,441 $44.63 187
2014 Q1 35,129,454 $1,319,227,424 +$12,262,867 $37.56 169